WO1999026614A1
(en)
*
|
1997-11-21 |
1999-06-03 |
Euro-Celtique S.A. |
Substituted 2-aminoacetamides and the use thereof
|
DK1277754T3
(en)
*
|
2000-04-27 |
2005-11-14 |
Astellas Pharma Inc |
imidazopyridine
|
DE10117184A1
(en)
*
|
2001-04-05 |
2002-10-17 |
Gruenenthal Gmbh |
Substituted imidazole [1,2-a] pyridin-3-yl amide and amine compounds
|
US7186714B2
(en)
|
2001-06-21 |
2007-03-06 |
Smithkline Beecham Corporation |
Imidazo[1,2-α]pyridine derivatives for the prophylaxis and treatment of herpes viral infections
|
IL159811A0
(en)
*
|
2001-07-13 |
2004-06-20 |
Neurogen Corp |
Heteroaryl substituted fused bicyclic heteroaryl compounds as gabaa receptor ligands
|
ES2262893T3
(en)
|
2001-10-05 |
2006-12-01 |
Smithkline Beecham Corporation |
IMIDAZO-PIRIDINE DERIVATIVES FOR USE IN THE TREATMENT OF VIRIC INFECTION BY HERPES.
|
DE60222465T2
(en)
|
2001-12-11 |
2008-06-05 |
Smithkline Beecham Corp. |
PYRAZOLOPYRIDINE DERIVATIVES AS ANTI-HERPING AGENTS
|
AU2003217712A1
(en)
|
2002-03-07 |
2003-09-22 |
Smithkline Beecham Corporation |
Pyrazolopyrimidine and pyrazolotriazine derivatives and pharmaceutical compositions containing them
|
CA2482991A1
(en)
|
2002-04-19 |
2003-10-30 |
Cellular Genomics, Inc. |
Imidazo[1,2-a]pyrazin-8-ylamines method of making and method of use thereof
|
EP1504004B1
(en)
|
2002-05-10 |
2007-06-27 |
SmithKline Beecham Corporation |
Substituted pyrazolopyrimidines
|
US7312341B2
(en)
|
2002-09-09 |
2007-12-25 |
Cgi Pharmaceuticals, Inc. |
6-aryl-imidazo[1,2-a] pyrazin-8-ylamines, method of making, and method of use thereof
|
US6992080B2
(en)
*
|
2002-09-19 |
2006-01-31 |
Schering Corporation |
Imidazopyridines as cyclin dependent kinase inhibitors
|
DE10246890A1
(en)
|
2002-10-08 |
2004-04-22 |
Grünenthal GmbH |
New C-(imidazo-(1,2-a)-pyridin-3-yl)-methylamines, are nitrogen monoxide synthase inhibitors useful e.g. for treating migraine, septic shock, neurodegenerative diseases, inflammatory pain or cancer
|
US7160885B2
(en)
|
2003-02-10 |
2007-01-09 |
Cgi Pharmaceuticals, Inc. |
Certain 6, 8-(heteroaryl or aryl) disubstituted imidazo[1,2-a]pyrazines as modulators of Hsp90 complex activity
|
US7405295B2
(en)
|
2003-06-04 |
2008-07-29 |
Cgi Pharmaceuticals, Inc. |
Certain imidazo[1,2-a]pyrazin-8-ylamines and method of inhibition of Bruton's tyrosine kinase by such compounds
|
WO2005005429A1
(en)
|
2003-06-30 |
2005-01-20 |
Cellular Genomics, Inc. |
Certain heterocyclic substituted imidazo[1,2-a]pyrazin-8-ylamines and methods of inhibition of bruton’s tyrosine kinase by such compounds
|
US7259164B2
(en)
|
2003-08-11 |
2007-08-21 |
Cgi Pharmaceuticals, Inc. |
Certain substituted imidazo[1,2-a]pyrazines, as modulators of kinase activity
|
KR101300831B1
(en)
*
|
2005-03-21 |
2013-08-30 |
에스*바이오 피티이 리미티드 |
IMlDAZO[1,2-a]PYRIDINE DERⅣATⅣES, PREPARATION AND PHARMACEUTICAL APPLICATIONS
|
US7777040B2
(en)
|
2005-05-03 |
2010-08-17 |
Cgi Pharmaceuticals, Inc. |
Certain substituted ureas, as modulators of kinase activity
|
TW200800213A
(en)
|
2005-09-02 |
2008-01-01 |
Abbott Lab |
Novel imidazo based heterocycles
|
CA2654202A1
(en)
|
2006-06-06 |
2007-12-21 |
Schering Corporation |
Imidazopyrazines as protein kinase inhibitors
|
CA2672172C
(en)
|
2006-12-22 |
2016-05-03 |
Astex Therapeutics Limited |
Bicyclic heterocyclic compounds as fgfr inhibitors
|
AU2007337895C1
(en)
|
2006-12-22 |
2014-07-31 |
Astex Therapeutics Limited |
Tricyclic amine derivatives as protein tyrosine kinase inhibitors
|
GB0720038D0
(en)
|
2007-10-12 |
2007-11-21 |
Astex Therapeutics Ltd |
New compounds
|
GB0720041D0
(en)
|
2007-10-12 |
2007-11-21 |
Astex Therapeutics Ltd |
New Compounds
|
JP5496915B2
(en)
|
2008-02-13 |
2014-05-21 |
シージーアイ ファーマシューティカルズ,インコーポレーテッド |
6-Aryl-imidazo [1,2-a] pyrazine derivatives, methods for their preparation, and methods for their use
|
EP2291187B1
(en)
*
|
2008-04-24 |
2018-08-15 |
Newlink Genetics Corporation |
Ido inhibitors
|
CN102112475A
(en)
*
|
2008-05-29 |
2011-06-29 |
西特里斯药业公司 |
Imidazopyridine and related analogs as sirtuin modulators
|
GB0810902D0
(en)
|
2008-06-13 |
2008-07-23 |
Astex Therapeutics Ltd |
New compounds
|
US8450321B2
(en)
|
2008-12-08 |
2013-05-28 |
Gilead Connecticut, Inc. |
6-(1H-indazol-6-yl)-N-[4-(morpholin-4-yl)phenyl]imidazo-[1,2-A]pyrazin-8-amine, or a pharmaceutically acceptable salt thereof, as a SYK inhibitor
|
CN104744476B
(en)
|
2008-12-08 |
2017-04-12 |
吉利德康涅狄格公司 |
IMIDAZOPYRAZINE Syk INHIBITORS
|
JP5696052B2
(en)
|
2008-12-08 |
2015-04-08 |
ギリアード コネチカット, インコーポレイテッド |
Imidazopyrazine SYK inhibitor
|
GB0906472D0
(en)
|
2009-04-15 |
2009-05-20 |
Astex Therapeutics Ltd |
New compounds
|
GB0906470D0
(en)
|
2009-04-15 |
2009-05-20 |
Astex Therapeutics Ltd |
New compounds
|
CN102596961B
(en)
|
2009-10-30 |
2015-12-02 |
詹森药业有限公司 |
Imidazo [1,2-b] pyridazine derivatives and the purposes as PDE10 inhibitor thereof
|
AR080754A1
(en)
|
2010-03-09 |
2012-05-09 |
Janssen Pharmaceutica Nv |
IMIDAZO DERIVATIVES (1,2-A) PIRAZINA AND ITS USE AS PDE10 INHIBITORS
|
PT2545052E
(en)
|
2010-03-11 |
2015-02-18 |
Gilead Connecticut Inc |
Imidazopyridines syk inhibitors
|
WO2012087833A1
(en)
|
2010-12-22 |
2012-06-28 |
Abbott Laboratories |
Hepatitis c inhibitors and uses thereof
|
BR112013033375B1
(en)
|
2011-06-27 |
2022-05-10 |
Janssen Pharmaceutica N.V |
Derivatives of 1-aryl-4-methyl-[1,2,4]triazolo[4,3-a]quinoxaline, their use, pharmaceutical composition that comprises them, process of preparation thereof, sterile solution and intermediate compound
|
DE102012200349A1
(en)
|
2012-01-11 |
2013-07-11 |
Bayer Intellectual Property Gmbh |
Substituted fused pyrimidines and triazines and their use
|
CA2872216C
(en)
|
2012-06-26 |
2021-07-20 |
Janssen Pharmaceutica Nv |
Combinations comprising pde 2 inhibitors such as 1-aryl-4-methyl-[1,2,4] triazolo [4,3-a] quinoxaline compounds and pde 10 inhibitors for use in the treatment of neurological or metabolic disorders
|
WO2014009305A1
(en)
|
2012-07-09 |
2014-01-16 |
Janssen Pharmaceutica Nv |
Inhibitors of phosphodiesterase 10 enzyme
|
US8796305B2
(en)
|
2012-11-05 |
2014-08-05 |
Bayer Pharma Aktiengesellschaft |
Carboxy-substituted imidazo[1,2-a]pyridinecarboxamides and their use
|
US9126998B2
(en)
|
2012-11-05 |
2015-09-08 |
Bayer Pharma AG |
Amino-substituted imidazo[1,2-a]pyridinecarboxamides and their use
|
US8778964B2
(en)
|
2012-11-05 |
2014-07-15 |
Bayer Pharma Aktiengesellschaft |
Hydroxy-substituted imidazo[1,2-a]-pyridinecarboxamides and their use
|
US9624214B2
(en)
|
2012-11-05 |
2017-04-18 |
Bayer Pharma Aktiengesellschaft |
Amino-substituted imidazo[1,2-a]pyridinecarboxamides and their use
|
US9556169B2
(en)
|
2012-11-19 |
2017-01-31 |
Novartis Ag |
Compounds and compositions for the treatment of parasitic diseases
|
AU2014254392B2
(en)
*
|
2013-03-15 |
2018-05-24 |
Epizyme, Inc. |
Substituted benzene compounds
|
US9243001B2
(en)
*
|
2013-03-15 |
2016-01-26 |
Epizyme, Inc. |
Substituted benzene compounds
|
CN105339368B
(en)
|
2013-06-04 |
2017-08-15 |
拜耳制药股份公司 |
Imidazo [1,2 a] pyridine of 3 aryl substitution and application thereof
|
AU2014289312A1
(en)
|
2013-07-10 |
2016-02-11 |
Bayer Pharma Aktiengesellschaft |
Benzyl-1H-pyrazolo(3,4-b)pyridines and use thereof
|
AP2016009007A0
(en)
|
2013-07-30 |
2016-01-31 |
Gilead Connecticut Inc |
Formulation of syk inhibitors
|
ES2822285T3
(en)
|
2013-07-30 |
2021-04-30 |
Kronos Bio Inc |
SYK inhibitor polymorph
|
ES2835549T3
(en)
|
2013-12-04 |
2021-06-22 |
Kronos Bio Inc |
Cancer treatment methods
|
US9290505B2
(en)
|
2013-12-23 |
2016-03-22 |
Gilead Sciences, Inc. |
Substituted imidazo[1,2-a]pyrazines as Syk inhibitors
|
TWI662037B
(en)
|
2013-12-23 |
2019-06-11 |
美商基利科學股份有限公司 |
Syk inhibitors
|
JP2017507140A
(en)
|
2014-02-19 |
2017-03-16 |
バイエル・ファルマ・アクティエンゲゼルシャフト |
3- (Pyrimidin-2-yl) imidazo [1,2-a] pyridine
|
JP2017508810A
(en)
|
2014-03-21 |
2017-03-30 |
バイエル・ファルマ・アクティエンゲゼルシャフト |
Cyano-substituted imidazo [1,2-a] pyridinecarboxamide and uses thereof
|
JP2017514898A
(en)
|
2014-05-02 |
2017-06-08 |
バイエル・ファルマ・アクティエンゲゼルシャフト |
N- (2-amino-5-fluoro-2-methylpentyl) -8-[(2,6-difluorobenzyl) oxy] -2-methylimidazo [1,2-A] for the treatment of cardiovascular disease Enantiomers of pyridine-3-carboxamide and of di- and trifluoro derivatives
|
MA40075A
(en)
|
2014-07-14 |
2016-01-21 |
Gilead Sciences Inc |
Combinations for treating cancers
|
EP3227286B1
(en)
|
2014-12-02 |
2018-12-26 |
Bayer Pharma Aktiengesellschaft |
Substituted pyrazolo[1,5-a]pyridines and imidazo[1,2-a]pyrazines and their use
|
JP2017536396A
(en)
|
2014-12-02 |
2017-12-07 |
バイエル・ファルマ・アクティエンゲゼルシャフト |
Heteroaryl substituted imidazo [1,2-a] pyridines and uses thereof
|
EP3286185A1
(en)
|
2015-02-05 |
2018-02-28 |
Bayer Pharma Aktiengesellschaft |
Substituted pyrazolo[1,5-a]-pyridine-3-carboxamides and use thereof
|
CA2975668A1
(en)
|
2015-02-05 |
2016-08-11 |
Bayer Pharma Aktiengesellschaft |
Substituted imidazo[1,2-a]pyrazine carboxamides and use thereof
|
WO2016161572A1
(en)
*
|
2015-04-08 |
2016-10-13 |
Merck Sharp & Dohme Corp. |
TrkA KINASE INHIBITORS, COMPOSITIONS AND METHODS THEREOF
|
WO2018184976A1
(en)
|
2017-04-05 |
2018-10-11 |
Bayer Pharma Aktiengesellschaft |
Substituted imidazo[1,2-a]pyridinecarboxamides and use of same
|
KR102399996B1
(en)
|
2017-08-25 |
2022-05-20 |
길리애드 사이언시즈, 인코포레이티드 |
Polymorphs of SYK Inhibitors
|
KR20210131372A
(en)
|
2019-02-22 |
2021-11-02 |
크로노스 바이오, 인코포레이티드 |
Solid Form of Condensed Pyrazine as Syk Inhibitor
|
US11718622B2
(en)
|
2020-03-16 |
2023-08-08 |
Exelixis Inc. |
Heterocyclic adenosine receptor antagonists
|